scholarly article | Q13442814 |
P2093 | author name string | Russell Schwartz | |
Stanley E Shackney | |||
Salim Akhter Chowdhury | |||
P2860 | cites work | The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer | Q42456997 |
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality | Q42458540 | ||
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma | Q42466578 | ||
P-cadherin, vimentin and CK14 for identification of basal-like phenotype in breast carcinomas: an immunohistochemical study | Q42472981 | ||
Minimum entropy clustering and applications to gene expression analysis. | Q46477092 | ||
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. | Q51584233 | ||
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. | Q51596197 | ||
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. | Q51925963 | ||
Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients. | Q52243870 | ||
Distinct gene expression phenotypes of cells lacking Rb and Rb family members | Q73608560 | ||
Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
Integrated genomic analyses of ovarian carcinoma | Q27860518 | ||
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
Molecular portraits of human breast tumours | Q28032461 | ||
Retinoblastoma protein represses transcription by recruiting a histone deacetylase | Q28262155 | ||
Rb interacts with histone deacetylase to repress transcription | Q28263985 | ||
TM4: a free, open-source system for microarray data management and analysis | Q29547339 | ||
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process | Q33281964 | ||
Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists | Q33331012 | ||
Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma | Q33348197 | ||
Network-based inference of cancer progression from microarray data | Q33437613 | ||
The Pezcoller lecture: cancer cell cycles revisited | Q33987290 | ||
The retinoblastoma tumour suppressor in development and cancer | Q34161991 | ||
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients | Q34557719 | ||
Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma | Q34595670 | ||
Molecular evolutionary patterns in breast cancer | Q35218427 | ||
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma | Q36338003 | ||
Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts | Q36559514 | ||
RB and hbrm cooperate to repress the activation functions of E2F1 | Q36591354 | ||
Basal-like breast cancer and the BRCA1 phenotype | Q36602561 | ||
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas | Q37038629 | ||
Cyclin E, a redundant cyclin in breast cancer | Q37089382 | ||
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Q37809456 | ||
Dissecting the heterogeneity of triple-negative breast cancer | Q37997760 | ||
Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis | Q38299703 | ||
The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer | Q39329911 | ||
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression | Q39628604 | ||
LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes | Q40099024 | ||
Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells | Q40243680 | ||
The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation. | Q40275037 | ||
Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1. | Q40563483 | ||
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product | Q40805644 | ||
P433 | issue | Suppl 5 | |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 89-100 | |
P577 | publication date | 2014-11-03 | |
P1433 | published in | Cancer Informatics | Q5031410 |
P1476 | title | A Novel Subset of Human Tumors That Simultaneously Overexpress Multiple E2F-responsive Genes Found in Breast, Ovarian, and Prostate Cancers | |
P478 | volume | 13 |
Q90211805 | Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer |
Q38836863 | Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures |
Q40571013 | Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis |
Q47550062 | Identification of Head and Neck Cancer Subtypes Based on Human Papillomavirus Presence and E2F-Regulated Gene Expression |
Q41862229 | Network and pathway analysis of cancer susceptibility (a). |
Q99584189 | Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer |
Q64061316 | Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer |
Q55153270 | Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. |
Q41243144 | Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures |
Q50136365 | Viral sequences in human cancer |
Q58561870 | ZNF703 is Overexpressed in Papillary Thyroid Carcinoma Tissues and Mediates K1 Cell Proliferation |
Search more.